Search Results - Pawlush, Matthew L.

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Abstract 5489: Synergistic activity of SCD1 blockade in combination with tyrosine kinase inhibitors lenvatinib and cabozantinib in hepatocellular carcinoma (HCC)

    Abstract 5489: Synergistic activity of SCD1 blockade in combination with tyrosine kinase inhibitors lenvatinib and cabozantinib in hepatocellular carcinoma (HCC) by Gleba, Justyna J., Alasonyalilar-Demirer, Aylin, Pawlush, Matthew L., Bilgili, Ahmet, Hickman, Peyton G., Mody, Kabir, Roberts, Lewis R., Alberts, Steven R., Truty, Mark J., Patel, Tushar C., Tun, Han W., Copland, John A.

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Abstract 5074: Addition of MAPK inhibitors to prime and sensitize poorly differentiated thyroid cancers as a strategy to improve TSHR-CART cell therapy antitumor activity

    Abstract 5074: Addition of MAPK inhibitors to prime and sensitize poorly differentiated thyroid cancers as a strategy to improve TSHR-CART cell therapy antitumor activity by Roman, Claudia Manriquez, Schick, Kendall J., Gleba, Justyna J., Huynh, Truc N., Siegler, Elizabeth L., Miller, James L., Demirer, Aylin Alasonyalilar, Pawlush, Matthew L., Biligili, Ahmet, Mai, Long K., Tapper, Erin, Sakemura, Leo R., Cox, Michelle J., Stewart, Carli M., Can, Ismail, Ogbodo, Ekene J., Cui, Gaofeng, Mer, Georges, Olivier, Gloria R., Qiu, Yushi, Smallridge, Robert C., Abba, Zubair C., Tun, Han W., Copland, John A., Kenderian, Saad S.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: